{"id":55962,"name":"ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.","slug":"elusys-therapeutics-inc-fka-nighthawk-biosciences-inc","state":"NC","country":"United States of America","description":"Biotechnology/pharmaceutical & biomanufacturing company","totalSpending":1800000,"filings":13,"yearlySpending":[{"year":2023,"income":490000},{"year":2024,"income":540000},{"year":2025,"income":770000}],"issues":["HCR","DEF","BUD"],"firms":["ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC."],"lobbyists":["RYAN KANE"],"govEntities":["Defense, Dept of (DOD)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Office of Science & Technology Policy (OSTP)","Natl Security Council (NSC)","Homeland Security, Dept of (DHS)"],"sampleDescriptions":["Healthcare, pharmaceutical, and emergency preparedness issues","Healthcare, pharmaceutical, and emergency preparedness issues","Healthcare, pharmaceutical, and emergency preparedness issues","PAHPA, NDAA, Appropriations issues relevant to healthcare, biodefense, infectious disease, biomanufacturing.","National Defense Authorization Act for 2024 Pandemic and All Hazards Preparedness Act Reauthorization 2024 Appropriations Issues Other issues related to biodefense/Preparedness/biomanufacturing"],"years":[2023,2024,2025]}